BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34708659)

  • 1. Diaminomaleonitrile derivatives as new potential antichagasic compounds: a study of structure-activity relationships.
    de Oliveira AS; S Mello LD; H Ogihara C; H Döring T; L Palomino-Salcedo D; Michelan-Duarte S; Lg Ferreira L; M Souza J; Dávila-Rodríguez MJ; Cruz Júnior JWD; R Dockal E; D Andricopulo A
    Future Med Chem; 2021 Dec; 13(24):2167-2183. PubMed ID: 34708659
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.
    Pauli I; Ferreira LG; de Souza ML; Oliva G; Ferreira RS; Dessoy MA; Slafer BW; Dias LC; Andricopulo AD
    Future Med Chem; 2017 May; 9(7):641-657. PubMed ID: 28509592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain Inhibitors.
    Avelar LA; Camilo CD; de Albuquerque S; Fernandes WB; Gonçalez C; Kenny PW; Leitão A; McKerrow JH; Montanari CA; Orozco EV; Ribeiro JF; Rocha JR; Rosini F; Saidel ME
    PLoS Negl Trop Dis; 2015; 9(7):e0003916. PubMed ID: 26173110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel trypanocidal thiophen-chalcone cruzain inhibitors: structure- and ligand-based studies.
    de Oliveira AS; Valli M; Ferreira LL; Souza JM; Krogh R; Meier L; Abreu HR; Voltolini BG; Llanes LC; Nunes RJ; Braga AL; Andricopulo AD
    Future Med Chem; 2022 Jun; 14(11):795-808. PubMed ID: 35543430
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis, in vitro and in vivo anti-Trypanosoma cruzi and toxicological activities of nitroaromatic Schiff bases.
    Cunha Almeida T; Gonzaga Ribeiro LH; Ferreira Dos Santos LB; da Silva CM; Tupinambá Branquinho R; de Lana M; Ramos Gadelha F; de Fátima Â
    Biomed Pharmacother; 2018 Dec; 108():1703-1711. PubMed ID: 30372873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular design aided by random forests and synthesis of potent trypanocidal agents as cruzain inhibitors for Chagas disease treatment.
    de Albuquerque S; Cianni L; de Vita D; Duque C; Gomes ASM; Gomes P; Laughton C; Leitão A; Montanari CA; Montanari R; Ribeiro JFR; da Silva JS; Teixeira C
    Chem Biol Drug Des; 2020 Sep; 96(3):948-960. PubMed ID: 33058457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
    Elizondo-Jimenez S; Moreno-Herrera A; Reyes-Olivares R; Dorantes-Gonzalez E; Nogueda-Torres B; Oliveira EAG; Romeiro NC; Lima LM; Palos I; Rivera G
    Med Chem; 2017; 13(2):149-158. PubMed ID: 27396731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational modification of Mannich base-type derivatives as novel antichagasic compounds: Synthesis, in vitro and in vivo evaluation.
    Paucar R; Martín-Escolano R; Moreno-Viguri E; Azqueta A; Cirauqui N; Marín C; Sánchez-Moreno M; Pérez-Silanes S
    Bioorg Med Chem; 2019 Sep; 27(17):3902-3917. PubMed ID: 31345745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmanicidal and trypanocidal activities of 2-aminocyclohexanol and 1,2-cyclohexanediamine derivatives.
    Rebollo O; del Olmo E; Ruiz G; López-Pérez JL; Giménez A; San Feliciano A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):184-7. PubMed ID: 18024033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and tripanocidal activity of ferrocenyl and benzyl diamines against Trypanosoma brucei and Trypanosoma cruzi.
    Velásquez AM; Francisco AI; Kohatsu AA; Silva FA; Rodrigues DF; Teixeira RG; Chiari BG; de Almeida MG; Isaac VL; Vargas MD; Cicarelli RM
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1707-10. PubMed ID: 24630563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
    Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
    Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, activity, and molecular modeling studies of 1,2,3-triazole derivatives from natural phenylpropanoids as new trypanocidal agents.
    de Souza TB; Caldas IS; Paula FR; Rodrigues CC; Carvalho DT; Dias DF
    Chem Biol Drug Des; 2020 Jan; 95(1):124-129. PubMed ID: 31569301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors.
    Burtoloso AC; de Albuquerque S; Furber M; Gomes JC; Gonçalez C; Kenny PW; Leitão A; Montanari CA; Quilles JC; Ribeiro JF; Rocha JR
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005343. PubMed ID: 28222138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrafluorophenoxymethyl ketone cruzain inhibitors with improved pharmacokinetic properties as therapeutic leads for Chagas' disease.
    Neitz RJ; Bryant C; Chen S; Gut J; Hugo Caselli E; Ponce S; Chowdhury S; Xu H; Arkin MR; Ellman JA; Renslo AR
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4834-4837. PubMed ID: 26144347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents.
    Ferreira RS; Dessoy MA; Pauli I; Souza ML; Krogh R; Sales AI; Oliva G; Dias LC; Andricopulo AD
    J Med Chem; 2014 Mar; 57(6):2380-92. PubMed ID: 24533839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CoMFA-SIMCA model for antichagasic nitrofurazone derivatives.
    Martinez-Merino V; Cerecetto H
    Bioorg Med Chem; 2001 Apr; 9(4):1025-30. PubMed ID: 11354658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New potent 5-substituted benzofuroxans as inhibitors of Trypanosoma cruzi growth: quantitative structure-activity relationship studies.
    Aguirre G; Boiani L; Boiani M; Cerecetto H; Di Maio R; González M; Porcal W; Denicola A; Piro OE; Castellano EE; Sant'Anna CM; Barreiro EJ
    Bioorg Med Chem; 2005 Dec; 13(23):6336-46. PubMed ID: 16202608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation.
    Cardoso MV; de Siqueira LR; da Silva EB; Costa LB; Hernandes MZ; Rabello MM; Ferreira RS; da Cruz LF; Moreira DR; Pereira VR; de Castro MC; Bernhardt PV; Leite AC
    Eur J Med Chem; 2014 Oct; 86():48-59. PubMed ID: 25147146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro and in silico studies of 1H- and 2H-1,2,3-triazoles as antichagasic agents.
    Silva TB; Ji KNK; Petzold Pauli F; Galvão RMS; Faria AFM; Bello ML; Resende JALC; Campos VR; Forezi LDSM; da Silva FC; Faria RX; Ferreira VF
    Bioorg Chem; 2021 Nov; 116():105250. PubMed ID: 34469833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.